The validity period of online orders: 3 months from the purchase date.
The Respiratory Syncytial Virus Vaccine (RSV Vaccine Abrysvo) is designed to protect against respiratory (lung) diseases caused by the respiratory syncytial virus (RSV). It is one of the most common viruses that can cause serious complications in infants, older adults, and individuals with chronic diseases.
Who is the RSV Vaccine Abrysvo for?
RSV vaccination is recommended for:
- Pregnant women – to protect infants from birth to 6 months of age.
- Individuals aged 60 and older – to reduce the risk of severe respiratory infections and complications.
What is RSV?
RSV (respiratory syncytial virus) is a common virus that causes mild, cold-like symptoms, such as:
- Sore throat,
- Cough,
- Nasal congestion.
While the illness often passes easily, RSV can be very dangerous for certain groups.
Why is RSV dangerous?
- In infants, RSV can cause serious lung diseases, such as bronchiolitis or pneumonia.
- For older adults and those with chronic diseases (e.g., COPD – chronic obstructive pulmonary disease, CHF – congestive heart failure), RSV can severely worsen health conditions.
- In some cases, RSV infection may require hospitalization and, in severe cases, can result in death.
Why get vaccinated against RSV?
Vaccination against RSV offers reliable protection that helps reduce the risk of severe cases, especially for those at highest risk of complications. The Abrysvo vaccine provides protection both to newborns (through vaccination of the mother during pregnancy) and older individuals.
